نتایج جستجو برای: abiraterone acetate

تعداد نتایج: 50619  

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2012
Mark N Stein Susan Goodin Robert S Dipaola

Abiraterone acetate is an orally administered potent inhibitor of cytochrome P450, family 17, subfamily A, polypeptide 1 (CYP17), which is essential for synthesis of testosterone from cholesterol. Although decreasing serum testosterone through inhibition of testicular function is the first line of treatment for men with metastatic prostate cancer, residual androgens may still be detected in pat...

Journal: :Oncology 2013
Elizabeth R Kessler Thomas W Flaig

In their article in this issue of ONCOLOGY, Drs. Hurwitz and Petrylak have very effectively reviewed recent progress in the treatment of advanced prostate cancer.[1] Enhanced understanding of the biologic drivers of disease progression and treatment resistance has led to prolific research, new therapeutic discoveries, and the timely approval of new agents. The authors note that currently the pr...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2011
Daniel C Danila Martin Fleisher Howard I Scher

Unmet needs in prostate cancer drug development and patient management are the ability to monitor treatment effects and to identify therapeutic targets in a tumor at the time treatment is being considered. This review focuses on establishing analytically valid biomarkers for specific contexts of use in patients with castration-resistant prostate cancer (CRPC), emphasizing a biomarker currently ...

2017
Matthew E. Pollard Alan J. Moskowitz Michael A. Diefenbach Simon J. Hall

Objective Treatment options for metastatic castration resistant prostate cancer (mCRPC) have expanded rapidly in recent years. Given the significant economic burden, we sought perform a cost-effectiveness analysis (CEA) of the contemporary treatment paradigm for mCRPC. Methods We devised a treatment protocol consisting of sipuleucel-T, enzalutamide, abiraterone, docetaxel, radium-223, and cab...

Journal: :European urology 2015
Bruce Montgomery Thian Kheoh Arturo Molina Jinhui Li Joaquim Bellmunt NamPhuong Tran Yohann Loriot Eleni Efstathiou Charles J Ryan Howard I Scher Johann S de Bono

BACKGROUND Corticosteroids have been used to mitigate mineralocorticoid-related effects and restore sensitivity to abiraterone acetate. Corticosteroids may also mediate glucocorticoid receptor or mutated androgen receptor activation and adversely influence outcome. OBJECTIVE This post hoc exploratory analysis investigated whether baseline corticosteroids were an independent prognostic factor ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید